Home
Services
Corporate and M&A

Corporate and M&A

We advise clients on domestic and cross-border public and private transactions as well as on governance and regulatory issues. We use our market knowledge to anticipate clients' needs and help them achieve their aims with a bespoke service that is client-focused and delivers on our commitment to excellence.

From large ground-breaking to mid-market transactions, we cover a wide spectrum in terms of both complexity and size without compromising on the quality of our service.
We have a proven ability to handle the most complex and demanding equity capital markets work for our clients. Acting for a mixture of issuers, sponsors and shareholders means that we understand corporate transactions from every angle.
Our partners counsel boards and senior executives in relation to the full range of corporate governance and regulatory compliance issues. Our advice is delivered with an understanding of the commercial objectives of the business and an understanding of the sector and environment in which it is operating.

Expertise:

Recent work

Hyve Group plc

Advising Hyve Group plc, a next-generation global events business, on a recommended takeover bid for it by funds advised by Providence Equity. The takeover values Hyve at approximately £320m and is expected to be implemented by way of a court-approved scheme of arrangement.

Mayfair Equity Partners

Mayfair Equity Partners on its backing of Access Partnership’s management buyout.

Siris

Advising Siris on the £673m recommended public-to-private takeover of Equiniti Group plc.

Aberdeen Asset Management plc.

Advising Aberdeen Asset Management plc on their acquisition of Finimize, an investment information platform.

Exponent

Advising Exponent on its acquisition of H&MV Engineering Limited.

Stonehage Fleming

Advising Stonehage Fleming on its acquisition of the private client services business of Maitland International Holdings plc.

The founders of Greencoat

Advising the founders of Greencoat on the sale of a majority stake in the business to Schroders.

Littelfuse Inc

Advising Littelfuse, Inc. an industrial technology manufacturing company, on its proposed all-cash acquisition of C&K Switches from an affiliate of global private equity firm Sun Capital Partners, Inc. for an enterprise value of $540m.

The BBC and Digital UK

Advising the BBC and Digital UK in relation to the merger of the Digital UK and Freesat operations and the admission of Channel 5 as a member.

Genius Sports Group

Advsing Genius Sports Group on a number of acquisitions including the acquisition of Spirable, a leading creative performance platform.

Ocado

Advising Ocado on its investment in British autonomous driving software company Wayve Technologies Limited.

Tulip Oil Holding B.V.

Advising Tulip Oil Holding B.V. on the sale of its 90% stake in German oil and gas company, Rhein Petroleum GmbH, to Beacon Energy plc.

PJT Partners

Advising PJT Partners in respect of $28bn take-private of Horizon Therapeutics plc by Amgen Inc.

Investec

Advising Investec, a leading bank and wealth manager, on an all-share combination of Investec Wealth & Investment Limited and Rathbones Group plc to create the UK’s leading discretionary wealth manager.

Investec

Capital One

Advising Capital One Financial Corporation, a Fortune 500 financial holding company, on its acquisition of Velocity Black, a leading digital concierge company that delivers travel, entertainment, shopping and dining offerings to consumers globally.

Capital One

MM Capital Partners

Advising MM Capital Partners on its acquisition of an interest in Queen Alexandra Hospital (Portsmouth).

Superdry plc

Advising Superdry plc on an joint venture with Reliance and the sale of Superdry’s intellectual property assets in India, Sri Lanka, and Bangladesh to the joint venture vehicle.

NortonLifeLock Inc.

Advising NortonLifeLock Inc., a NASDAQ-listed provider of consumer Cyber Safety solutions, on its recommended cash and stock merger with FTSE 100 company Avast plc, a leading global cybersecurity provider, in a transaction attributing an enterprise value to Avast of up to $9.7bn

Jazz Pharmaceuticals

Advising Jazz Pharmaceuticals plc, a biopharmaceutical company based in Ireland, on its acquisition of GW Pharmaceuticals plc for a total consideration of $7.2bn.

See all

See all contacts